- Home
- NCRA vs GOVX Comparison
NCRA vs GOVX Comparison
Compare NCRA & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCRA
- GOVX
- Stock Information
- Founded
- NCRA 2002
- GOVX 2001
- Country
- NCRA Taiwan
- GOVX United States
- Employees
- NCRA N/A
- GOVX N/A
- Industry
- NCRA Farming/Seeds/Milling
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- NCRA Consumer Staples
- GOVX Health Care
- Exchange
- NCRA Nasdaq
- GOVX Nasdaq
- Market Cap
- NCRA 16.1M
- GOVX 16.8M
- IPO Year
- NCRA N/A
- GOVX N/A
- Fundamental
- Price
- NCRA $1.01
- GOVX $0.38
- Analyst Decision
- NCRA
- GOVX Strong Buy
- Analyst Count
- NCRA 0
- GOVX 2
- Target Price
- NCRA N/A
- GOVX $7.00
- AVG Volume (30 Days)
- NCRA 1.9M
- GOVX 571.6K
- Earning Date
- NCRA 11-14-2025
- GOVX 11-13-2025
- Dividend Yield
- NCRA N/A
- GOVX N/A
- EPS Growth
- NCRA N/A
- GOVX N/A
- EPS
- NCRA N/A
- GOVX N/A
- Revenue
- NCRA $14,106,275.00
- GOVX $3,353,560.00
- Revenue This Year
- NCRA N/A
- GOVX N/A
- Revenue Next Year
- NCRA N/A
- GOVX N/A
- P/E Ratio
- NCRA N/A
- GOVX N/A
- Revenue Growth
- NCRA N/A
- GOVX 8.52
- 52 Week Low
- NCRA $0.70
- GOVX $0.38
- 52 Week High
- NCRA $2.40
- GOVX $3.15
- Technical
- Relative Strength Index (RSI)
- NCRA 34.29
- GOVX 24.55
- Support Level
- NCRA $0.94
- GOVX $0.46
- Resistance Level
- NCRA $1.14
- GOVX $0.44
- Average True Range (ATR)
- NCRA 0.12
- GOVX 0.03
- MACD
- NCRA -0.02
- GOVX -0.01
- Stochastic Oscillator
- NCRA 17.74
- GOVX 3.77
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.